scholarly journals Hemiplegic Migraine in Glut1 Deficiency Syndrome and Paroxysmal Dyskinesia at Ketogenic Diet Induction: Case Report and Literature Review

2020 ◽  
Vol 7 (8) ◽  
pp. 965-970
Author(s):  
Janina Gburek‐Augustat ◽  
Anja Heinze ◽  
Rami Abou Jamra ◽  
Andreas Merkenschlager
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Ketogenic Diet ◽  
Deficiency Syndrome ◽  
Hemiplegic Migraine ◽  
Paroxysmal Dyskinesia ◽  
Glut1 Deficiency ◽  
Glut1 Deficiency Syndrome

Refractory Absence Epilepsy and Glut1 Deficiency Syndrome: A New Case Report and Literature Review

2014 ◽  
Vol 45 (05) ◽  
pp. 328-332 ◽  
Author(s):  
Francesca Ragona ◽  
Sara Matricardi ◽  
Barbara Castellotti ◽  
Mara Patrini ◽  
Elena Freri ◽  
...  
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Deficiency Syndrome ◽  
Absence Epilepsy ◽  
Glut1 Deficiency ◽  
Glut1 Deficiency Syndrome

scholarly journals GLUT1 deficiency syndrome: A case report with a novel SLC2A1 mutation

2019 ◽  
Vol 76 (5) ◽  
pp. 543-546 ◽  
Author(s):  
Nikola Ivancevic ◽  
Natasa Cerovac ◽  
Blazo Nikolic ◽  
Goran Cuturilo ◽  
Ana Marjanovic ◽  
...  
Keyword(s):  
Case Report ◽  
Developmental Delay ◽  
Ketogenic Diet ◽  
Glucose Transporter ◽  
Deficiency Syndrome ◽  
Chromosome 1 ◽  
Brain Membrane ◽  
Slc2a1 Gene ◽  
Glut1 Deficiency ◽  
Glut1 Deficiency Syndrome

Introduction. GLUT1 deficiency syndrome (GLUT1 DS, OMIM 606777) is a metabolic brain disorder caused by mutations in SLC2A1 gene (chromosome 1) encoding glucose transporter type 1 located on blood-brain membrane. The ?classic? phenotype in children includes early onset generalized farmacoresistant epilepsy, developmental delay, complex movement disorders and acquired microcephaly. However, there are milder phenotypes without epilepsy which could be seen in older children. The ketogenic diet is a treatment of choice. Case report. We present a four-yearold female patient with farmacoresistant generalized epilepsy, paroxysmal dystonic posturing, ataxia, hypotonia, developmental delay (motor, attention and speech disturbances), and microcephaly. The genetic testing revealed a novel point mutation at c.156T > A (p.Y52X) in exon 3 of SLC2A1 gene. The patient responded excellent on ketogenic diet. Conclusion. GLUT1 DS is treatable, and likely to be under-diagnosed neurological disorder. The ketogenic diet is resulting in good control of seizures in the patients, and it has certain benefit for the neurodevelopmental disability.

Transition from ketogenic diet to triheptanoin in patients with GLUT1 deficiency syndrome

2019 ◽  
Vol 91 (4) ◽  
pp. 444-445 ◽  
Author(s):  
Elodie Hainque ◽  
Aurélie Meneret ◽  
Domitille Gras ◽  
Mariana Atencio ◽  
Marie-Pierre Luton ◽  
...  
Keyword(s):  
Ketogenic Diet ◽  
Deficiency Syndrome ◽  
Glut1 Deficiency ◽  
Glut1 Deficiency Syndrome

Neutropenia responsive to ketogenic diet in an infant with GLUT1 deficiency syndrome

2015 ◽  
Vol 02 (02) ◽  
pp. 137-140
Author(s):  
Marianne Ifversen ◽  
Jakob Ek ◽  
Peter Uldall ◽  
Henrik Simonsen ◽  
Cristel Sørensen
Keyword(s):  
Ketogenic Diet ◽  
Deficiency Syndrome ◽  
Glut1 Deficiency ◽  
Glut1 Deficiency Syndrome

Seizure Control and Acceptance of the Ketogenic Diet in GLUT1 Deficiency Syndrome: A 2- to 5-Year Follow-Up of 15 Children Enrolled Prospectively

2005 ◽  
Vol 36 (5) ◽  
pp. 302-308 ◽  
Author(s):  
J. Klepper ◽  
H. Scheffer ◽  
B. Leiendecker ◽  
E. Gertsen ◽  
S. Binder ◽  
...  
Keyword(s):  
Ketogenic Diet ◽  
Seizure Control ◽  
Deficiency Syndrome ◽  
Glut1 Deficiency ◽  
Glut1 Deficiency Syndrome

scholarly journals Total Intravenous Anesthesia in GLUT1 Deficiency Syndrome Patient: A Case Report

2019 ◽  
Vol 20 ◽  
pp. 647-650
Author(s):  
Jan Kloka ◽  
Stefanie Kranepuhl ◽  
Kai Zacharowski ◽  
Florian Jürgen Raimann
Keyword(s):  
Case Report ◽  
Deficiency Syndrome ◽  
Total Intravenous Anesthesia ◽  
Syndrome Patient ◽  
Intravenous Anesthesia ◽  
Glut1 Deficiency ◽  
Glut1 Deficiency Syndrome

Occurrence of GLUT1 deficiency syndrome in patients treated with ketogenic diet

2014 ◽  
Vol 32 ◽  
pp. 76-78 ◽  
Author(s):  
Anette Ramm-Pettersen ◽  
Karl O. Nakken ◽  
Kathrine Cammermeyer Haavardsholm ◽  
Kaja Kristine Selmer
Keyword(s):  
Ketogenic Diet ◽  
Deficiency Syndrome ◽  
Glut1 Deficiency ◽  
Glut1 Deficiency Syndrome

scholarly journals Clinical and Genetic Characteristics of Chinese Children With GLUT1 Deficiency Syndrome: Case Report and Literature Review

2021 ◽  
Vol 12 ◽  
Author(s):  
Qingqing Hu ◽  
Yuechi Shen ◽  
Tangfeng Su ◽  
Yan Liu ◽  
Sanqing Xu
Keyword(s):  
Developmental Delay ◽  
Ketogenic Diet ◽  
Movement Disorders ◽  
Epileptic Seizures ◽  
Deficiency Syndrome ◽  
Chinese Children ◽  
Chinese Family ◽  
Slc2a1 Gene ◽  
Glut1 Deficiency ◽  
Glut1 Deficiency Syndrome

Objective: GLUT1 deficiency syndrome (GLUT1-DS) is a rare, treatable neurometabolic disorder. However, its diagnosis may be challenging due to the various and evolving phenotypes. Here we report the first Chinese familial cases with genetically confirmed GLUT1-DS and analyze the characteristics of Chinese children with GLUT1-DS from clinical, laboratory, and genetic aspects.Methods: We reported a Chinese family with three members affected with GLUT1-DS and searched for relevant articles up to September 2020 from PubMed, WOS, CNKI, and WanFang databases. A total of 30 Chinese patients diagnosed with GLUT1-DS (three newly identified patients in one family and 27 previously reported ones) were included and analyzed in this study.Results: The median age of onset of the 30 patients (male: 18, female: 12) was 8.5 months (range, 33 days to 10 years). Epileptic seizures were found in 25 patients, most with generalized tonic–clonic and focal ones. Movement disorders were found in 20 patients—frequently with ataxia and dystonia, developmental delay in 25 patients, and microcephaly only in six patients. The cerebrospinal fluid (CSF) analysis showed decreased CSF glucose (median: 1.63 mmol/L, range: 1.1–2.6 mmol/L) and glucose ratio of CSF to blood (median: 0.340; range: 0.215–0.484). The genetic testing performed in 28 patients revealed 27 cases with pathogenic variations of the SLC2A1 gene, including 10 missense, nine frameshift, three nonsense, three large fragment deletions, and two splice-site mutations. Most patients had a good response to the treatment of ketogenic diet or regular diet with increased frequency. Although three patients in this Chinese family carried the same pathogenic mutation c.73C > T (p.Q25X) in the SLC2A1 gene, their symptoms and responses to treatment were not exactly the same.Conclusion: The clinical manifestations of GLUT1-DS are heterogeneous, even among family members sharing the same mutation. For children with unexplained epileptic seizures, developmental delay, and complex movement disorders, detection of low CSF glucose or SLC2A1 gene mutations is helpful for the diagnosis of GLUT1-DS. Early initiation of ketogenic diet treatment significantly improves the symptoms and prognosis of GLUT1-DS.

Failure of ketogenic diet therapy in GLUT1 deficiency syndrome

2019 ◽  
Vol 23 (3) ◽  
pp. 404-409 ◽  
Author(s):  
Yvonne A.C. Bekker ◽  
Danielle A. Lambrechts ◽  
Judith S. Verhoeven ◽  
Jessy van Boxtel ◽  
Caroline Troost ◽  
...  
Keyword(s):  
Ketogenic Diet ◽  
Diet Therapy ◽  
Deficiency Syndrome ◽  
Glut1 Deficiency ◽  
Glut1 Deficiency Syndrome
Sign in / Sign up

Export Citation Format

Share Document